Arena Pharmaceuticals
HOME CONTACT US SITE MAP
 

INVESTOR OVERVIEW
PRESS RELEASES
EVENTS & PRESENTATIONS
ANALYST COVERAGE
ANNUAL REPORTS
CORPORATE GOVERNANCE
STOCK INFORMATION
SEC FILINGS
EMAIL ALERTS
CONTACT IR
 
Press Releases

All Releases
View Summary Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 3
Jul 27, 2010
PDF 8.7 KB Add to Briefcase
View Summary New England Journal of Medicine Publishes Results of Two-Year BLOOM Trial Showing Lorcaserin Caused Significant Weight Loss and Improved Maintenance of Weight Loss
Jul 14, 2010
PDF 13.4 KB Add to Briefcase
View Summary Eisai to Market Arena Pharmaceuticals' Lorcaserin for Obesity and Weight Management in U.S. Following FDA Approval
Jul 1, 2010
PDF 13.9 KB Add to Briefcase
View Summary Arena Pharmaceuticals' Lorcaserin Reduces Body Weight and Improves Cardiovascular Risk Factors Across Patient Subgroups
Jun 26, 2010
PDF 10.1 KB Add to Briefcase
View Summary Arena Pharmaceuticals' Lorcaserin to Be Featured in Presentations at the American Diabetes Association's 70th Scientific Sessions
Jun 17, 2010
PDF 10.2 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
Jun 4, 2010
PDF 8.4 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Receive $35.5 Million from Deerfield Management
Jun 3, 2010
PDF 8.7 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Notification of Tentative September 16th FDA Advisory Committee Meeting to Review Lorcaserin for Weight Management
Jun 2, 2010
PDF 9.9 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces First Quarter 2010 Financial Results and Recent Developments
May 7, 2010
PDF 14.5 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the Ninth Annual JMP Securities Research Conference
May 6, 2010
PDF 8.4 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Friday, May 7, 2010
Apr 30, 2010
PDF 8.5 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the Deutsche Bank 35th Annual Health Care Conference
Apr 28, 2010
PDF 8.4 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of APD916 for Narcolepsy and Cataplexy
Mar 24, 2010
PDF 9.5 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the Barclays Capital 2010 Global Healthcare Conference
Mar 18, 2010
PDF 8.3 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2009 Financial Results
Mar 12, 2010
PDF 20.2 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the Cowen and Company 30th Annual Health Care Conference
Mar 8, 2010
PDF 8.3 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Friday, March 12, 2010
Mar 8, 2010
PDF 8.5 KB Add to Briefcase
View Summary Arena Pharmaceuticals Receives PDUFA Date for Lorcaserin NDA
Feb 26, 2010
PDF 9.8 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces FDA Acceptance of Lorcaserin NDA for Filing
Feb 24, 2010
PDF 9.6 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
Feb 4, 2010
PDF 8.2 KB Add to Briefcase
Showing 1-20 of 324 Page: 1 2 3 4 5 ... 17  Next 20
Add to Briefcase = add release to Briefcase
 

Additional Information regarding Arena is available in its SEC filings
© Copyright 2000-2010 Arena Pharmaceuticals, Inc.
All Rights Reserverd
Terms and Conditions
Privacy Statement


ABOUT US PRODUCT CANDIDATES RESEARCH PROGRAMS GPCR TECHNOLOGY INVESTORS CAREERS